• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

AMO phaco system offers dual-pump fluidics

Article

San Diego?Advanced Medical Optics (AMO) Inc. has introduced a new phacoemulsification system featuring dual-pump fluidics (WhiteStar Signature with Fusion).

San Diego-Advanced Medical Optics (AMO) Inc. has introduced a new phacoemulsification system featuring dual-pump fluidics (WhiteStar Signature with Fusion).

The system "combines the efficiency and safety of [existing] phaco technology with improved fluidics that enhance chamber stability," said David F. Chang, MD, clinical professor of ophthalmology, University of California, San Francisco. "The dual pump represents the next generation in phaco fluidics."

According to the company, the fluidics technology reduces post-occlusion surge by a significant margin, and the dual-pump responsiveness offers the performance of a venturi pump and the control of a peristaltic flow-based pump. Also, the system consists of a streamlined user interface and accessories-including a one-step, one-hand cassette; a touch screen; and a help feature that is designed to ease use of the equipment during surgery.

Related Videos
Neda Nikpoor, MD, talks about the Light Adjustable Lens at ASCRS 2024
© 2024 MJH Life Sciences

All rights reserved.